-
SB 202190: Translational Control of p38 Signaling
2026-08-31
A thought-leadership perspective on using SB202190 (FHPI) to dissect p38α/β biology, validate pathway causality, and strengthen translational studies spanning inflammation research, cancer therapeutics research, and neurodegeneration.
-
Moxidectin: From Anthelmintic to Assay Variable
2026-08-30
Moxidectin is more than a veterinary antiparasitic: emerging evidence shows it can reshape Candida albicans ergosterol biology and potentiate polyenes. This article translates that cross-domain finding into evidence-aware assay design, interpretation, and product-handling decisions.
-
Pseudo-UTP for mRNA Synthesis and RNA Stability
2026-08-29
Pseudo-UTP enables controlled pseudouridine incorporation during in vitro transcription, helping researchers compare RNA stability, translation, and immune-response profiles. This practical guide connects reagent handling and assay design with an Omicron KP.3 mRNA vaccine study while keeping product-specific evidence separate from workflow recommendations.
-
RIPA Lysis Buffer (Strong) for Bone Protein Assays
2026-08-29
RIPA Lysis Buffer (Strong) supports reproducible protein extraction from cultured cells and animal tissues for Western blotting, immunoprecipitation, ELISA, and kinase-focused experiments. Its detergent-rich formulation is especially useful when robust lysis and phosphoprotein preservation matter, provided that inhibitor supplementation and assay compatibility are managed carefully.
-
KRas Transfer by Tunneling Nanotubes in Tumors
2026-08-28
This 2024 Acta Biomaterialia study shows that tunneling nanotubes can transfer mutant KRas between tumor cells, linking horizontal oncogene movement with reduced membrane tension and faster phospholipid flow. By combining confocal fluorescence imaging, optical tweezers, and gene interference, the work positions tumor-cell mechanics as a functional component of heterogeneity, invasion, and potential disease monitoring.
-
Gentamycin Sulfate: Ribosome & Resistance Research
2026-08-28
Gentamycin Sulfate is an aminoglycoside antibiotic research reagent that disrupts bacterial decoding at the 30S ribosomal subunit. Its defined product specifications and established mechanism support bacterial protein synthesis research, ribosome function analysis, and antibiotic resistance studies, but they do not replace organism-specific susceptibility testing.
-
STING agonist-1: From Signal to Assay Design
2026-08-27
STING agonist-1 provides a controlled way to study innate immune signaling, B-cell activation, and tumor-associated tertiary lymphoid structures. This article translates recent ESCC findings into practical assay decisions while defining what a small-molecule STING perturbation can—and cannot—prove.
-
Mitochondrial Permeability Transition Pore Assay Kit
2026-08-27
Turn mitochondrial pore opening into a measurable live-cell fluorescence readout for drug screening, disease modeling, and cell death mechanism research. This workflow shows how to combine the Calcein AM fluorescent probe with controls, normalization, and orthogonal mitochondrial endpoints for more defensible results.
-
SCP4, H3T3 Dephosphorylation, and Chromosome Stability
2026-08-26
The reference study identifies SCP4 as a nuclear phosphatase that removes the mitotic H3T3 phosphate and helps position the chromosomal passenger complex on chromosomes. Cellular and mouse-zygote evidence connects disrupted SCP4 activity with chromosome missegregation, lagging chromosomes, and aneuploidy, clarifying a previously unresolved layer of mitotic control.
-
GSK126 EZH2 Inhibitor: Workflow & Uses
2026-08-26
GSK126 provides a selective, dose-responsive way to interrogate EZH2/PRC2-dependent H3K27me3 and gene silencing. This practical guide connects cancer epigenetics research with a reference-informed decidual CXCL10 assay while emphasizing controls, compound handling, and interpretation limits.
-
Annexin V-FITC/PI Apoptosis Assay Kit Workflow
2026-08-25
Build a rapid, two-color apoptosis assay that separates viable, early apoptotic, and membrane-compromised cells in one experiment. This workflow shows how to apply Annexin V-FITC/PI staining to nickel nanoparticle lung-injury models, treatment studies, flow cytometry, and microscopy while avoiding common interpretation and handling errors.
-
Halazone and Sodium Current Inactivation in Frog Nerves
2026-08-25
The 1986 frog nerve study used Halazone and related chemical reagents to distinguish oxidative effects on sodium-current inactivation from simple shifts in voltage dependence. Its results argue against a uniquely critical methionine residue and instead support a cautious membrane-lipid explanation, while also defining a rigorous voltage-clamp framework for interpreting chemical modulation of ion channels.
-
HyperScript III RT SuperMix for CRC qPCR
2026-08-24
Translate bile acid–based colorectal cancer subtyping into reliable CLCA1, UGT2A3, and ZG16 expression assays, even when RNA is scarce, GC-rich, or vulnerable to genomic DNA carryover. This workflow combines gDNA cleanup, broad transcript priming, and flexible SYBR Green or probe-based detection for stronger biomarker validation.
-
ML365: From Channel Blockade to Assay Design
2026-08-23
ML365 is a selective TASK1 potassium channel probe with value beyond a nanomolar IC50. This article shows how to connect orthogonal channel assays with NLRP3, oxidative-stress, histology, and behavioral endpoints while preserving mechanistic caution.
-
Halazone and Sodium Current Inactivation
2026-08-22
The 1986 frog nerve study used a comparative chemical-reagent strategy to test which molecular groups might control sodium-current inactivation. Halazone and hypochlorous acid strongly disrupted inactivation, whereas several other oxidants and residue-selective reagents produced distinct or modest effects, shifting interpretation away from a uniquely critical methionine residue and toward a tentative membrane-lipid mechanism.
449 records 6/30 page Previous Next First page 上5页 678910 下5页 Last page